$2.1 million drug to treat rare genetic disease approved by FDA

México Noticias Noticias

$2.1 million drug to treat rare genetic disease approved by FDA
México Últimas Noticias,México Titulares
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 86%

FDA approved a drug to treat a rare and fatal genetic disease in children, a life-saving therapy that will cost $2.1M.

They don't know if their children will ever walk. But finding other families online has given them hope.

She remembers watching a video for one the trials that showed the impact of a single dose of gene therapy in pigs. Initially the pigs were shown dragging their feet, but after therapy, “it show[ed] the pig walking perfectly,” Almeida said. “We knew right away that this was it. This was what we wanted for Matt.”

“Critics are not actually thinking about how our healthcare systems work,” Vas Narasimhan said. “For transplants, we spend $3 million to $5 million [per patient] with far less efficacy than we see with a medicine like this. We’re trying to price this at 50 percent of what is the current cost of care over ten years for these children.”

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

NBCNews /  🏆 10. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Gene therapy gets FDA approval -- and a $2 million price tagGene therapy gets FDA approval -- and a $2 million price tagThe FDA approved a treatment for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2. The price tag? $2.125 million for a one-time treatment.
Leer más »

U.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorderU.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorderZURICH/NEW YORK - Swiss drugmaker Novartis won U.S. approval for its gene therap...
Leer más »

Novartis $2 million gene therapy for rare disorder is world's most expensive drugNovartis $2 million gene therapy for rare disorder is world's most expensive drugSwiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA) and priced the one-time treatment at a record $2.125 million
Leer más »

At $2 Million, New Novartis Drug Is Priciest EverAt $2 Million, New Novartis Drug Is Priciest EverNovartis said it plans to price its recently approved gene therapy at $2.125 million, making it the world’s most expensive medicine.
Leer más »

This $2 app changed the way I workThis $2 app changed the way I work.NBCNewsBETTER: With the Pomodoro Technique, you pick a task, set a timer for 25 minutes to work on that one thing, take a 5-minute break when the timer rings and repeat.
Leer más »

Geoffrey Rush awarded $2 million in Sydney defamation caseGeoffrey Rush awarded $2 million in Sydney defamation caseOscar-winning actor Geoffrey Rush awarded $2 million in defamation case over reports he had been accused of inappropriate behavior toward an actress.
Leer más »

Monsanto faces thousands of Roundup-cancer lawsuits after $2 billion verdictMonsanto faces thousands of Roundup-cancer lawsuits after $2 billion verdict“We’re not suing them for the fact that their product causes cancer. We’re suing them because they didn’t tell people that it causes cancer.”
Leer más »

RNC paid $2 million to law firm employing former White House counsel Donald McGahnRNC paid $2 million to law firm employing former White House counsel Donald McGahnThe RNC said the payment encompassed two years of work by the law firm Jones Day on a variety of matters.
Leer más »

Nascar to buy International Speedway in deal valued at $2 billion, at a 7% premium to original per-share bidNascar to buy International Speedway in deal valued at $2 billion, at a 7% premium to original per-share bidInternational Speedway Corp. announced Wednesday a deal to be acquired by Nascar Holdings Inc. in a deal valued at $2.0 billion. Under terms of the deal,...
Leer más »



Render Time: 2025-03-04 07:22:58